Published in Brain on December 05, 2013
Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. Neuron (2014) 1.30
Merlin controls the repair capacity of Schwann cells after injury by regulating Hippo/YAP activity. J Cell Biol (2017) 0.90
The importance of nerve microenvironment for schwannoma development. Acta Neuropathol (2016) 0.89
Role of Merlin/NF2 inactivation in tumor biology. Oncogene (2015) 0.85
Neuronal involvement in muscular atrophy. Front Cell Neurosci (2014) 0.84
A neuronal function of the tumor suppressor protein merlin. Acta Neuropathol Commun (2014) 0.83
Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury. Neurobiol Dis (2015) 0.81
Regulating Axonal Responses to Injury: The Intersection between Signaling Pathways Involved in Axon Myelination and The Inhibition of Axon Regeneration. Front Mol Neurosci (2016) 0.79
Schwannomin-interacting protein 1 isoform IQCJ-SCHIP1 is a multi-partner ankyrin and spectrin binding protein involved in the organization of nodes of Ranvier. J Biol Chem (2016) 0.75
Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration. PLoS One (2016) 0.75
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA (1997) 8.30
Axonal neuregulin-1 regulates myelin sheath thickness. Science (2004) 6.09
Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci (2008) 4.91
Neuregulin-1 type III determines the ensheathment fate of axons. Neuron (2005) 4.19
Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J Cell Biol (1982) 3.85
Notch signaling in the mammalian central nervous system: insights from mouse mutants. Nat Neurosci (2005) 3.67
The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev (2001) 3.65
Neurofibromatosis 2. Curr Opin Neurol (2003) 3.46
Production of dissociated sensory neuron cultures and considerations for their use in studying neuronal function and plasticity. Nat Protoc (2007) 2.88
Axonal regulation of myelination by neuregulin 1. Curr Opin Neurobiol (2006) 2.78
Gpr126 is essential for peripheral nerve development and myelination in mammals. Development (2011) 1.77
Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2. Proc Natl Acad Sci U S A (1995) 1.73
Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas. Oncogene (2008) 1.57
Specific regulation of NRG1 isoform expression by neuronal activity. J Neurosci (2011) 1.46
Notch signaling inhibits axon regeneration. Neuron (2012) 1.26
Mechanisms and roles of axon-Schwann cell interactions. J Neurosci (2004) 1.21
Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3. J Cell Biol (1997) 1.20
TACE (ADAM17) inhibits Schwann cell myelination. Nat Neurosci (2011) 1.14
Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function. Proc Natl Acad Sci U S A (2011) 1.13
Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination. Glia (2011) 1.04
Synergistic regulation of Schwann cell proliferation by heregulin and forskolin. Mol Cell Biol (1998) 1.04
The role of neuregulin-1 in the response to nerve injury. Future Neurol (2011) 1.03
Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy. Nat Neurosci (2013) 1.01
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study. Otol Neurotol (2008) 1.01
Schwann cell myelination requires integration of laminin activities. J Cell Sci (2012) 1.00
Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis. Mol Cell Biol (2003) 0.97
Neuron-glia signaling and the protection of axon function by Schwann cells. J Peripher Nerv Syst (2010) 0.97
Merlin inhibits neurite outgrowth in the CNS. J Neurosci (2010) 0.93
Neuregulin-1 isoforms are differentially expressed in the intact and regenerating adult rat nervous system. J Mol Neurosci (2003) 0.91
Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy. J Neuropathol Exp Neurol (2010) 0.89
Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens. Acta Neuropathol (2002) 0.88
Neu (c-erbB-2), a tumor marker in carcinoma of the female breast. Pathobiology (1990) 0.84
Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-tooth disease type 1A. Muscle Nerve (2006) 0.82
[Expressional changes of neuregulin-1 gene mRNA in peripheral blood from schizophrenia patients]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2011) 0.81
The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain (2012) 2.49
Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase. Nature (2006) 2.15
The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1. Dev Med Child Neurol (2012) 1.50
Prolonged glial expression of Sox4 in the CNS leads to architectural cerebellar defects and ataxia. J Neurosci (2007) 1.50
Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin. Mol Biol Cell (2006) 1.43
Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int (2005) 1.33
Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. Eur J Nucl Med Mol Imaging (2006) 1.32
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro Oncol (2009) 1.28
Listeria monocytogenes exploits ERM protein functions to efficiently spread from cell to cell. EMBO J (2005) 1.28
Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2. Clin Cancer Res (2008) 1.24
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. Am J Med Genet A (2011) 1.24
Low-grade and anaplastic gliomas: differences in architecture evaluated with diffusion-tensor MR imaging. Radiology (2006) 1.22
Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma. Blood (2013) 1.19
Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1. Orphanet J Rare Dis (2012) 1.17
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathol (2015) 1.16
A microRNA contribution to aberrant Ras activation in gastric cancer. Am J Transl Res (2011) 1.14
Collapsin response mediator protein-4 regulates F-actin bundling. Exp Cell Res (2005) 1.14
Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits. J Pediatr (2011) 1.09
Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients. Am J Surg Pathol (2012) 1.02
Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients. BMC Cancer (2005) 1.01
Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy. Nat Neurosci (2013) 1.01
Jaw malformations plus displacement and numerical aberrations of teeth in neurofibromatosis type 1: a descriptive analysis of 48 patients based on panoramic radiographs and oral findings. J Craniomaxillofac Surg (2003) 1.01
Neurocutaneous melanosis: report of three cases and up-to-date review. J Child Neurol (2008) 0.99
Atypical focal MRI lesions in a case of juvenile Alexander's disease. Ann Neurol (2003) 0.98
Besides Purkinje cells and granule neurons: an appraisal of the cell biology of the interneurons of the cerebellar cortex. Histochem Cell Biol (2008) 0.98
Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling. Hum Mol Genet (2002) 0.97
Properties of an ezrin mutant defective in F-actin binding. J Mol Biol (2008) 0.97
Embryonic stem cell-derived neuronally committed precursor cells with reduced teratoma formation after transplantation into the lesioned adult mouse brain. Stem Cells (2006) 0.97
Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1. Eur J Nucl Med Mol Imaging (2012) 0.96
Febrile seizures: recent developments and unanswered questions. Childs Nerv Syst (2013) 0.94
Extensively high load of internal tumors determined by whole body MRI scanning in a patient with neurofibromatosis type 1 and a non-LCR-mediated 2-Mb deletion in 17q11.2. Hum Genet (2005) 0.94
Merlin inhibits neurite outgrowth in the CNS. J Neurosci (2010) 0.93
Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer's disease. Brain Pathol (2011) 0.92
Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Clin Nucl Med (2013) 0.91
Well-differentiated neurocytoma: what is the best available treatment? Neuro Oncol (2005) 0.91
Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis. PLoS One (2012) 0.91
Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutation. Hum Mutat (2011) 0.91
Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1. J Med Genet (2010) 0.91
Transduction of peptides and proteins into live cells by cell penetrating peptides. J Cell Biochem (2011) 0.91
Histological findings in ruptured aneurysms treated with GDCs: six examples at varying times after treatment. AJNR Am J Neuroradiol (2003) 0.91
Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma. J Neurooncol (2010) 0.89
Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1. BMC Neurol (2013) 0.89
DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis. J Neurooncol (2012) 0.89
Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype. J Neurosurg (2006) 0.89
Efficacy and selectivity of nilotinib on NF1-associated tumors in vitro. J Neurooncol (2013) 0.89
A novel third type of recurrent NF1 microdeletion mediated by nonallelic homologous recombination between LRRC37B-containing low-copy repeats in 17q11.2. Hum Mutat (2010) 0.88
Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens. Acta Neuropathol (2002) 0.88
Hyaluronan is organized into fiber-like structures along migratory pathways in the developing mouse cerebellum. Matrix Biol (2007) 0.88
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies. PLoS One (2012) 0.88
Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis. J Clin Invest (2014) 0.88
Engrailed-2 negatively regulates the onset of perinatal Purkinje cell differentiation. J Comp Neurol (2004) 0.88
What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers. Am J Med Genet A (2010) 0.88
Secretory meningiomas: a benign subgroup causing life-threatening complications. Neuro Oncol (2009) 0.88
Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation. J Neuropathol Exp Neurol (2010) 0.87
Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. Hum Genomics (2012) 0.86
Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model. J Neurooncol (2009) 0.86
Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant. Ann Neurol (2004) 0.86
Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors. Mol Cancer Res (2004) 0.86
Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin. J Clin Pathol (2011) 0.85
Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein. Neuro Oncol (2002) 0.85
Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue. Acta Neuropathol (2003) 0.85
Internal tumor burden in neurofibromatosis Type I patients with large NF1 deletions. Genes Chromosomes Cancer (2012) 0.84
Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms. Acta Neuropathol (2014) 0.83
Developmental expression and differentiation-related neuron-specific splicing of metastasis suppressor 1 (Mtss1) in normal and transformed cerebellar cells. BMC Dev Biol (2007) 0.83
Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting. Acta Neuropathol (2011) 0.83
Cancer stem cell-like cells derived from malignant peripheral nerve sheath tumors. PLoS One (2011) 0.83
Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image. Dermatology (2012) 0.83
A neuronal function of the tumor suppressor protein merlin. Acta Neuropathol Commun (2014) 0.83
Neurocan-GFP fusion protein: a new approach to detect hyaluronan on tissue sections and living cells. J Histochem Cytochem (2004) 0.83
Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions. Neurogenetics (2012) 0.83
Nestin modulates glucocorticoid receptor function by cytoplasmic anchoring. PLoS One (2009) 0.83
Intrachromosomal mitotic nonallelic homologous recombination is the major molecular mechanism underlying type-2 NF1 deletions. Hum Mutat (2010) 0.82
Regulation of Son of sevenless by the membrane-actin linker protein ezrin. Proc Natl Acad Sci U S A (2013) 0.82
SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints. Genome Biol (2014) 0.82
Quantitative vascular pathology and phenotyping familial and sporadic cerebral small vessel diseases. Brain Pathol (2013) 0.82
Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up. Anticancer Res (2012) 0.82
Insulin-like growth factor-1 receptor (IGF-1R) in primary and metastatic undifferentiated carcinoma of the head and neck: a possible target of immunotherapy. Anticancer Res (2010) 0.82
Inhibition of RAS activation due to a homozygous ezrin variant in patients with profound intellectual disability. Hum Mutat (2015) 0.81
Apoptotic photoreceptor loss and altered expression of lysosomal proteins in the nclf mouse model of neuronal ceroid lipofuscinosis. Invest Ophthalmol Vis Sci (2013) 0.81
Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia. Am J Hematol (2013) 0.81
Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas. J Invest Dermatol (2008) 0.81
CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. Am J Med Genet A (2014) 0.81
Tetraspanin-5 (Tm4sf9) mRNA expression parallels neuronal maturation in the cerebellum of normal and L7En-2 transgenic mice. J Comp Neurol (2005) 0.81
Expression of doublecortin in tumours of the central and peripheral nervous system and in human non-neuronal tissues. Acta Neuropathol (2006) 0.80
Engrailed-2 regulates genes related to vesicle formation and transport in cerebellar Purkinje cells. Mol Cell Neurosci (2008) 0.80
Recurrent deep-vein thrombosis based on homozygous factor V Leiden mutation acquired after liver transplantation. Liver Transpl (2003) 0.80
Growth behavior of plexiform neurofibromas after surgery. Genet Med (2013) 0.80
Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas. Neuropathology (2012) 0.80
Physiological purkinje cell death is spatiotemporally organized in the developing mouse cerebellum. Cerebellum (2009) 0.79
Hypophysectomy for prostate cancer: a revival of old knowledge? J Neurosurg (2008) 0.79